Source: Frontiers in Drug Discovery. Unidade: EACH
Assunto: INIBIÇÃO
ABNT
SERAFIM, Mateus Sá Magalhães et al. The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study. Frontiers in Drug Discovery, v. 3, p. 01-18, 2023Tradução . . Disponível em: https://doi.org/10.3389/fddsv.2023.1237655. Acesso em: 29 ago. 2024.APA
Serafim, M. S. M., Pantaleão, S. Q., Silva, E. B. da, McKerrow, J. H., O’Donoghue, A. J., Mota, B. E. F., et al. (2023). The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study. Frontiers in Drug Discovery, 3, 01-18. doi:10.3389/fddsv.2023.1237655NLM
Serafim MSM, Pantaleão SQ, Silva EB da, McKerrow JH, O’Donoghue AJ, Mota BEF, Honorio KM, Maltarollo VG. The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study [Internet]. Frontiers in Drug Discovery. 2023 ; 3 01-18.[citado 2024 ago. 29 ] Available from: https://doi.org/10.3389/fddsv.2023.1237655Vancouver
Serafim MSM, Pantaleão SQ, Silva EB da, McKerrow JH, O’Donoghue AJ, Mota BEF, Honorio KM, Maltarollo VG. The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study [Internet]. Frontiers in Drug Discovery. 2023 ; 3 01-18.[citado 2024 ago. 29 ] Available from: https://doi.org/10.3389/fddsv.2023.1237655